Your browser doesn't support javascript.
loading
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
Yildirim, Hilin; Widdershoven, Christiaan V; Aarts, Maureen Jb; Bex, Axel; Bloemendal, Haiko J; Bochove-Overgaauw, Deirdre M; Hamberg, Paul; Herbschleb, Karin H; van der Hulle, Tom; Lagerveld, Brunolf W; van Oijen, Martijn Gh; Oosting, Sjoukje F; van Thienen, Johannes V; van der Veldt, Astrid Am; Westgeest, Hans M; Zeijdner, Evelijn E; Aben, Katja Kh; van den Hurk, Corina; Zondervan, Patricia J; Bins, Adriaan D.
Affiliation
  • Yildirim H; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands. h.yildirim@amsterdamumc.nl.
  • Widdershoven CV; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands. h.yildirim@amsterdamumc.nl.
  • Aarts MJ; Department of Urology, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands.
  • Bex A; Department of Medical Oncology, GROW-School for Oncology and Development Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
  • Bloemendal HJ; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Bochove-Overgaauw DM; The Royal Free London NHS Foundation Trust, London, UK.
  • Hamberg P; UCL Division of Surgery and Interventional Science, London, UK.
  • Herbschleb KH; Department of Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • van der Hulle T; Department of Urology, Gelre Hospitals, Apeldoorn/Zutphen, The Netherlands.
  • Lagerveld BW; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands.
  • van Oijen MG; Department of Internal Medicine, St. Antonius Ziekenhuis, Nieuwegein, The Netherlands.
  • Oosting SF; Department of Medical Oncology, LUMC, Leiden, the Netherlands.
  • van Thienen JV; Department of Urology, OLVG, Amsterdam, The Netherlands.
  • van der Veldt AA; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC location University of Amsterdam, 4F De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.
  • Westgeest HM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Zeijdner EE; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands.
  • Aben KK; Department of Medical Oncology, Department of Radiology & Nuclear Medicine, Erasmus Medical Center-Cancer Institute, Rotterdam, the Netherlands.
  • van den Hurk C; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.
  • Zondervan PJ; Dutch Oncology Research Platform, Utrecht, The Netherlands.
  • Bins AD; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
BMC Cancer ; 23(1): 648, 2023 Jul 11.
Article de En | MEDLINE | ID: mdl-37434119
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Ethics / Patient_preference Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Néphrocarcinome / Tumeurs du rein Type d'étude: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Aspects: Ethics / Patient_preference Limites: Humans Pays/Région comme sujet: Europa Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas